Loring Wolcott & Coolidge Fiduciary Advisors LLP Neogenomics Inc Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q2 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 08, 2018	SELL	$8.02 - $11.18 $882 - $1,229	-110 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$9.11 - $11.26 $1,002 - $1,238	110	110 $1,000

Others Institutions Holding NEO

# of Institutions

308

Shares Held

129M

Call Options Held

1.17M

Put Options Held

297K

Black Rock Inc. New York, NY

19.7M
Shares

$179 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14.1M
Shares

$129 Million
0.0% of portfolio
Greenhouse Funds Lllp Baltimore, MD

7.43M
Shares

$67.6 Million
2.32% of portfolio
First Light Asset Management, LLC Edina, MN

6.85M
Shares

$62.3 Million
7.69% of portfolio
State Street Corp Boston, MA

5.11M
Shares

$46.5 Million
0.0% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.14B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account